聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 15 分钟 26 秒 前

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

周二, 09/02/2014 - 13:19
MARLBOROUGH, Mass., Sept. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Bo...
Devices, Interventional, Mergers & Acquisitions
Boston Scientific, Bayer AG, AngioJet, Fetch 2, JetStream

Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business

周二, 09/02/2014 - 13:15
PLAINSBORO, N.J., Sept. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced that it has made changes to the leadership of its Orthopedics and Tissue Technologies business. The new organizati...
Devices, Orthopaedic, Personnel
Integra LifeSciences

Clearside Biomedical, Inc. Completes $16 Million Series B Financing

周二, 09/02/2014 - 12:56
ALPHARETTA, Ga.--(Healthcare Sales & Marketing Network)--Clearside Biomedical, Inc., today announced the closing of a $16 million Series B financing. The financing included new investor RusnanoMedInvest (RMI) and existing investors Hatteras Venture Partner...
Biopharmaceuticals, Ophthalmology, Venture Capital
Clearside Biomedica

Sorin Group Announces First World Implant of CROWN PRT(TM) Heart Valve

周二, 09/02/2014 - 12:46
New stented aortic bioprosthesis with outstanding ease of use and performance successfully implanted in Austria MILAN--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), (Reuters Code: SORN.MI), a global medical company and a leader in the tr...
Devices, Cardiology
Sorin Group, CROWN PRT, aortic bioprosthesis, heart valve

Elekta’s Versa HD Radiation Therapy System Now Available for Treatment of Cancer Patients in Japan

周二, 09/02/2014 - 12:35
Linear accelerator receives clearance from country’s Ministry of Health, Labor and Welfare STOCKHOLM--(Healthcare Sales & Marketing Network)--Cancer care providers in Japan have the opportunity to strengthen their cancer treatment capacity with the rece...
Devices, Oncology, Regulatory
Elekta, Versa HD, linear accelerator, radiotherapy

GE Healthcare Announces European Union Approval of VIZAMYL(TM) (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease

周一, 09/01/2014 - 18:43
PET Imaging Agent Receives Marketing Authorisation from the European Commission CHALFONT ST. GILES, England--(Healthcare Sales & Marketing Network)--GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received mar...
Biopharmaceuticals, Devices, Radiology, Oncology, Regulatory
GE Healthcare, VIZAMYL, Flutemetamol, Positron Emission Tomography

Covidien Acquires Venous Disease Treatment Developer Sapheon, Inc.

周四, 08/28/2014 - 16:34
Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veins DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced that it has acquired Sapheon, Inc., a pri...
Devices, Mergers & Acquisitions
Covidien, Sapheon, VenaSeal, varicose veins

Armetheon Completes $7.0 Million Series A Financing

周四, 08/28/2014 - 16:31
Company poised to enter final pivotal trial for novel oral anti-coagulant MENLO PARK, Calif., Aug. 28, 2014 -- (Healthcare Sales & Marketing Network) -- Armetheon, Inc. (www.armetheon.com), a biopharmaceutical company focused on developing novel mid- t...
Biopharmaceuticals, Cardiology, Venture Capital
Armetheon, Tecarfarin, Vitamin K epoxide reductase

Isogenica Appoints New Chief Executive Officer

周四, 08/28/2014 - 16:27
CAMBRIDGE, England--(Healthcare Sales & Marketing Network)--Isogenica are pleased to announce the appointment of Dr. Chris Ullman as CEO with effect from September 29th 2014, following the decision by Dr. Kevin Matthews to leave Isogenica to join a publicl...
Biopharmaceuticals, Personnel
Isogenica

Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia

周三, 08/27/2014 - 14:14
The third labeled indication for the drug Represents a new first-in-class treatment option for SAA patient population with insufficient response to immunosuppressive therapy SAN DIEGO--(Healthcare Sales & Marketing Network)--Ligand Pharmaceuticals I...
Biopharmaceuticals, FDA
Ligand Pharmaceuticals, GlaxoSmithKline, Promacta, Revolade, eltrombopag

Brainlab: First Patient Treatment with Revolutionary New Radiosurgery Software for Multiple Brain Metastases

周三, 08/27/2014 - 13:54
Automated treatment planning software by Brainlab sets a new benchmark in consistency, conformity and treatment efficiency MUNICH, Germany--(Healthcare Sales & Marketing Network)--New Automatic Brain Metastases Planning* software by Brainlab has been cl...
Devices, Oncology, Neurosurgery
Brainlab, radiosurgery, Automatic Brain Metastases Planning

Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing

周三, 08/27/2014 - 13:28
Investor syndicate includes leading biotech and mutual funds HOUSTON--(Healthcare Sales & Marketing Network)--Bellicum Pharmaceuticals, Inc., a biotechnology company focused on developing safer and more effective cellular immunotherapies, today announce...
Biopharmaceuticals, Venture Capital
Bellicum Pharmaceuticals

European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple Genotypes for the Treatment of Chronic Hepatitis C Infection

周三, 08/27/2014 - 13:23
Daklinza, when used in combination with sofosbuvir, is an all-oral, once daily regimen that yields cure rates of up to 100% Daklinza + sofosbuvir offers potential cure for a broad range of EU HCV patients, including those with advanced liver disease, g...
Biopharmaceuticals, Regulatory
Bristol-Myers Squibb, Daklinza, daclatasvir, hepatitis C

Ivera Medical Files Suit Against Catheter Connections After DualCap Product Fails to Disinfect in Independent Study

周三, 08/27/2014 - 13:18
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical announced that it has sued Catheter Connections for false advertising and unfair competition based on false claims that its dark blue IV-Pole Strips and DualCap products for male luer co...
Devices, Litigation
Ivera Medical, Catheter Connections

Highest level evidence published in Neurosurgery journal indicates better outcomes when using iMRI

周二, 08/26/2014 - 12:42
Interim analysis of triple-blind, parallel-controlled trial proves intraoperative MRI more effective than conventional neurosurgery for certain brain tumors MINNEAPOLIS, Aug. 26, 2014 -- (Healthcare Sales & Marketing Network) - IMRIS Inc. (NASDAQ: IM...
Devices, Radiology, Neurosurgery
IMRIS , VISIUS , intraoperative MRI

Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board

周二, 08/26/2014 - 12:36
DOYLESTOWN, Pa., Aug. 26, 2014 -- (Healthcare Sales & Marketing Network) -- Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announc...
Biopharmaceuticals, Personnel
Novira Therapeutics, hepatitis B

Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A

周二, 08/26/2014 - 12:32
Only Hemophilia A Therapy to Provide Bleeding Protection with Prophylactic Regimens of Either Every Three to Five Days or Once-Weekly Infusions MISSISSAUGA, ON,(Healthcare Sales & Marketing Network) - Today Biogen Idec (BIIB) announces that Health Canad...
Biopharmaceuticals, Regulatory
Biogen Idec, ELOCTATE, Antihemophilic Factor, hemophilia

Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors

周二, 08/26/2014 - 12:24
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the appointment of Richard C. Williams, Robert B. Rothermel and William C. Denby to its Board of Directors. Mr. Williams was also appo...
Biopharmaceuticals, Personnel
Adamis Pharmaceuticals

NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.

周一, 08/25/2014 - 16:23
eteran Medical Representatives Are Now Marketing NovaBay’s Innovative Eye Care Product to Ophthalmologists and Optometrists in Major Markets i-Lid Cleanser is Formulated to Help the 40 Million Patients Who Suffer From Blepharitis and Dry Eye EMERYVI...
Biopharmaceuticals, Ophthalmology, Distribution
NovaBay Pharmaceuticals, i-Lid Cleanser, blepharitis

Vaccinogen Completes Initial Closing of an $80 Million Financing

周一, 08/25/2014 - 13:00
Initial Closing is for $10 Million Benjamin S. Carson, MD, appointed Chairman of the Board Andrew L. Tussing named Chief Executive Officer FREDERICK, Md., Aug. 25, 2014 -- (Healthcare Sales & Marketing Network) -- Vaccinogen, Inc., (VGEN) a cance...
Biopharmaceuticlas, Oncology, Venture Capital
Vaccinogen, OncoVAX

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong